Discovery of a Novel Series of Tankyrase Inhibitors by a Hybridization Approach

Author:

Anumala Upendra Rao1,Waaler Jo23,Nkizinkiko Yves4,Ignatev Alexander4,Lazarow Katina1,Lindemann Peter1,Olsen Petter Angell23,Murthy Sudarshan4,Obaji Ezeogo4,Majouga Alexander G.5,Leonov Sergey67,von Kries Jens Peter18,Lehtiö Lari4ORCID,Krauss Stefan23,Nazaré Marc18ORCID

Affiliation:

1. Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Campus Berlin-Buch, 13125 Berlin, Germany

2. Unit for Cell Signaling, Institute of Medical Microbiology, Oslo University Hospital, Gaustadalleen 34, 0372 Oslo, Norway

3. Hybrid Technology Hub, Centre of Excellence, Institute of Basic Medical Sciences, University of Oslo, 0372 Oslo, Norway

4. Faculty of Biochemistry and Molecular Medicine, Biocenter Oulu, University of Oulu, P.O. Box 5400, 90014 Oulu, Finland

5. Department of Chemistry, Moscow State University, Leninskie Gory 1/3, Moscow 119991, Russia

6. National University of Science and Technology MISiS, Leninsky Avenue 4, Moscow 119049, Russia

7. Moscow Institute of Physics and Technology (State University), Institutskiy Lane 9, 141700 Dolgoprudny, Russia

8. Berlin Institute of Health (BIH), Anna-Louisa-Karsch-Strasse 2, 10178 Berlin, Germany

Funder

Sigrid Jus?liuksen S??ti?

Norges Forskningsr?d

Jane ja Aatos Erkon S??ti?

Suomen Akatemia

Ministry of Education and Science of the Russian Federation

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3